​

Bruker (BRKR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BRKR Stock Forecast

Bruker (BRKR) stock forecast, based on 29 Wall Street analysts, predicts a 12-month average price target of $72.00, with a high of $72.00 and a low of $72.00. This represents a 90.78% increase from the last price of $37.74.

$35 $47 $59 $71 $83 $95 High: $72 Avg: $72 Low: $72 Last Closed Price: $37.74

BRKR Stock Rating

Bruker stock's rating consensus is Buy, based on 29 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 17 Buy (58.62%), 11 Hold (37.93%), 1 Sell (3.45%), and 0 Strong Sell (0.00%).

Buy
Total 29 1 11 17 Strong Sell Sell Hold Buy Strong Buy

BRKR Price Target Upside V Benchmarks

TypeNameUpside
StockBruker90.78%
SectorHealthcare Stocks 35.25%
IndustryMedical Device Stocks21.20%

Price Target Trends

1M3M12M
# Anlaysts--4
Avg Price Target--$76.75
Last Closing Price$37.74$37.74$37.74
Upside/Downside--103.37%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25375--15
Mar, 25375--15
Feb, 25375--15
Jan, 25375--15
Dec, 24375-116
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 19, 2024Subbu NambiGuggenheim$72.00$55.7429.17%90.78%
Sep 23, 2024Patrick DonnellyCitigroup$80.00$67.5418.45%111.98%
Aug 27, 2024Brandon CouillardWells Fargo$78.00$63.9521.97%106.68%
May 20, 2024Daniel AriasStifel Nicolaus$77.00$76.470.69%104.03%
May 05, 2021Tycho PetersonJ.P. Morgan$60.00$68.86-12.87%58.98%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 19, 2024GuggenheimBuyinitialise
Dec 05, 2024Goldman SachsSellupgrade
Oct 15, 2024BarclaysOverweightinitialise
Sep 30, 2024Wolfe ResearchPeer Performdowngrade
Sep 23, 2024CitigroupBuyBuyhold
Aug 28, 2024Wells FargoOverweightPositiveinitialise
Aug 27, 2024Wells FargoOverweightinitialise
Aug 07, 2024Cowen & Co.HoldHoldhold
Jul 10, 2024CitigroupBuyBuyhold
May 20, 2024CitigroupBuyBuyhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.03$1.83$2.00$2.92$0.76----
Avg Forecast$1.33$2.09$2.32$2.55$2.39$2.68$3.04$3.49$3.76
High Forecast$1.35$2.12$2.33$2.58$2.40$2.73$3.08$3.55$3.82
Low Forecast$1.31$2.06$2.30$2.52$2.38$2.59$2.97$3.41$3.68
Surprise %-22.56%-12.44%-13.79%14.51%-68.20%----

Revenue Forecast

$2B $2B $3B $3B $4B $5B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.99B$2.42B$2.53B$2.96B$3.37B----
Avg Forecast$1.96B$2.40B$2.50B$2.92B$3.35B$3.56B$3.76B$4.02B$4.19B
High Forecast$1.98B$2.42B$2.51B$2.95B$3.39B$3.59B$3.78B$4.02B$4.23B
Low Forecast$1.94B$2.37B$2.48B$2.87B$3.34B$3.54B$3.75B$4.02B$4.11B
Surprise %1.26%0.83%1.20%1.66%0.40%----

Net Income Forecast

$100M $200M $300M $400M $500M $600M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$157.80M$277.10M$296.60M$427.20M$113.10M----
Avg Forecast$148.62M$215.24M$241.59M$427.20M$351.43M$391.14M$445.47M$512.28M$553.96M
High Forecast$178.34M$258.29M$289.91M$512.64M$352.90M$401.21M$453.91M$521.99M$562.22M
Low Forecast$118.89M$172.19M$193.27M$341.76M$349.97M$381.08M$437.03M$502.58M$541.32M
Surprise %6.18%28.74%22.77%--67.82%----

BRKR Forecast FAQ

Is Bruker stock a buy?

Bruker stock has a consensus rating of Buy, based on 29 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 17 Buy, 11 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Bruker is a favorable investment for most analysts.

What is Bruker's price target?

Bruker's price target, set by 29 Wall Street analysts, averages $72 over the next 12 months. The price target range spans from $72 at the low end to $72 at the high end, suggesting a potential 90.78% change from the previous closing price of $37.74.

How does Bruker stock forecast compare to its benchmarks?

Bruker's stock forecast shows a 90.78% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the medical device stocks industry (21.20%).

What is the breakdown of analyst ratings for Bruker over the past three months?

  • April 2025: 20.00% Strong Buy, 46.67% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 20.00% Strong Buy, 46.67% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 20.00% Strong Buy, 46.67% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.

What is Bruker’s EPS forecast?

Bruker's average annual EPS forecast for its fiscal year ending in December 2025 is $2.68, marking a 252.63% increase from the reported $0.76 in 2024. Estimates for the following years are $3.04 in 2026, $3.49 in 2027, and $3.76 in 2028.

What is Bruker’s revenue forecast?

Bruker's average annual revenue forecast for its fiscal year ending in December 2025 is $3.56B, reflecting a 5.76% increase from the reported $3.37B in 2024. The forecast for 2026 is $3.76B, followed by $4.02B for 2027, and $4.19B for 2028.

What is Bruker’s net income forecast?

Bruker's net income forecast for the fiscal year ending in December 2025 stands at $391.14M, representing an 245.84% increase from the reported $113.1M in 2024. Projections indicate $445.47M in 2026, $512.28M in 2027, and $553.96M in 2028.